Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Nanozymes help heal burn wounds by fighting bacteria, reducing inflammation, and promoting blood vessel growth.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Eight blood metabolites are linked to causing allergic conjunctivitis, offering new ways to predict and treat it.

Increased blood vessel growth in lichen planopilaris may signal active disease needing aggressive treatment.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Copper deficiency lowers blood and liver copper levels in rats, but not in hair or bones.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Eating foods with sulfhydryl may worsen pemphigus vulgaris.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

Hair loss in lupus patients indicates higher disease activity.

Cortisone in hair is a more reliable indicator of stress hormone exposure than cortisol.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

Betacellulin helps blood vessel growth in wounds but delays hair growth.

Placental cell medium boosts blood vessel growth in lab tests.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

Using one's own blood platelets and fat can improve facial and hair appearance without surgery.

Higher doses of glucocorticoids increase the risk of blood clots in asthma patients.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.